Aflac (AFL) Competitors

67.4% of Aflac shares are held by institutional investors. Comparatively, 97.4% of AMERISAFE shares are held by institutional investors. 0.8% of Aflac shares are held by insiders. Comparatively, 2.0% of AMERISAFE shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Aflac had 25 more articles in the media than AMERISAFE. MarketBeat recorded 29 mentions for Aflac and 4 mentions for AMERISAFE. AMERISAFE's average media sentiment score of 1.67 beat Aflac's score of 0.55 indicating that AMERISAFE is being referred to more favorably in the news media.

Aflac pays an annual dividend of $2.44 per share and has a dividend yield of 2.1%. AMERISAFE pays an annual dividend of $1.64 per share and has a dividend yield of 6.6%. Aflac pays out 26.2% of its earnings in the form of a dividend. AMERISAFE pays out 66.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Aflac has raised its dividend for 44 consecutive years and AMERISAFE has raised its dividend for 12 consecutive years.

Aflac has a net margin of 26.91% compared to AMERISAFE's net margin of 14.00%. AMERISAFE's return on equity of 14.87% beat Aflac's return on equity.

Aflac has higher revenue and earnings than AMERISAFE. AMERISAFE is trading at a lower price-to-earnings ratio than Aflac, indicating that it is currently the more affordable of the two stocks.

Aflac has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, AMERISAFE has a beta of 0.23, suggesting that its stock price is 77% less volatile than the broader market.

Aflac currently has a consensus price target of $116.62, suggesting a potential upside of 1.16%. AMERISAFE has a consensus price target of $44.00, suggesting a potential upside of 77.63%. Given AMERISAFE's higher probable upside, analysts plainly believe AMERISAFE is more favorable than Aflac.

In the previous week, Aflac had 23 more articles in the media than Trupanion. MarketBeat recorded 29 mentions for Aflac and 6 mentions for Trupanion. Trupanion's average media sentiment score of 0.93 beat Aflac's score of 0.55 indicating that Trupanion is being referred to more favorably in the media.

67.4% of Aflac shares are owned by institutional investors. 5.6% of Trupanion shares are owned by insiders. Comparatively, 0.8% of Aflac shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Aflac has a net margin of 26.91% compared to Trupanion's net margin of 1.53%. Aflac's return on equity of 13.27% beat Trupanion's return on equity.

Trupanion presently has a consensus target price of $39.20, suggesting a potential upside of 57.49%. Aflac has a consensus target price of $116.62, suggesting a potential upside of 1.16%. Given Trupanion's stronger consensus rating and higher possible upside, research analysts plainly believe Trupanion is more favorable than Aflac.

Trupanion has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market. Comparatively, Aflac has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market.

Aflac has higher revenue and earnings than Trupanion. Aflac is trading at a lower price-to-earnings ratio than Trupanion, indicating that it is currently the more affordable of the two stocks.

In the previous week, Aflac had 12 more articles in the media than Allstate. MarketBeat recorded 29 mentions for Aflac and 17 mentions for Allstate. Allstate's average media sentiment score of 0.69 beat Aflac's score of 0.55 indicating that Allstate is being referred to more favorably in the media.

Allstate has a beta of 0.15, suggesting that its share price is 85% less volatile than the broader market. Comparatively, Aflac has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

Aflac has a net margin of 26.91% compared to Allstate's net margin of 18.97%. Allstate's return on equity of 41.64% beat Aflac's return on equity.

Allstate currently has a consensus target price of $263.90, suggesting a potential upside of 3.99%. Aflac has a consensus target price of $116.62, suggesting a potential upside of 1.16%. Given Allstate's stronger consensus rating and higher probable upside, research analysts plainly believe Allstate is more favorable than Aflac.

Allstate has higher revenue and earnings than Aflac. Allstate is trading at a lower price-to-earnings ratio than Aflac, indicating that it is currently the more affordable of the two stocks.

76.5% of Allstate shares are owned by institutional investors. Comparatively, 67.4% of Aflac shares are owned by institutional investors. 1.6% of Allstate shares are owned by insiders. Comparatively, 0.8% of Aflac shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Allstate pays an annual dividend of $4.32 per share and has a dividend yield of 1.7%. Aflac pays an annual dividend of $2.44 per share and has a dividend yield of 2.1%. Allstate pays out 8.6% of its earnings in the form of a dividend. Aflac pays out 26.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Allstate has raised its dividend for 15 consecutive years and Aflac has raised its dividend for 44 consecutive years. Aflac is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Aflac had 26 more articles in the media than Employers. MarketBeat recorded 29 mentions for Aflac and 3 mentions for Employers. Employers' average media sentiment score of 1.77 beat Aflac's score of 0.55 indicating that Employers is being referred to more favorably in the news media.

Aflac currently has a consensus price target of $116.62, indicating a potential upside of 1.16%. Employers has a consensus price target of $59.00, indicating a potential upside of 18.96%. Given Employers' stronger consensus rating and higher probable upside, analysts plainly believe Employers is more favorable than Aflac.

Aflac has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, Employers has a beta of 0.47, indicating that its stock price is 53% less volatile than the broader market.

Aflac pays an annual dividend of $2.44 per share and has a dividend yield of 2.1%. Employers pays an annual dividend of $1.36 per share and has a dividend yield of 2.7%. Aflac pays out 26.2% of its earnings in the form of a dividend. Employers pays out 197.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Aflac has raised its dividend for 44 consecutive years and Employers has raised its dividend for 4 consecutive years.

Aflac has a net margin of 26.91% compared to Employers' net margin of 0.91%. Aflac's return on equity of 13.27% beat Employers' return on equity.

67.4% of Aflac shares are owned by institutional investors. Comparatively, 80.5% of Employers shares are owned by institutional investors. 0.8% of Aflac shares are owned by insiders. Comparatively, 1.3% of Employers shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Aflac has higher revenue and earnings than Employers. Aflac is trading at a lower price-to-earnings ratio than Employers, indicating that it is currently the more affordable of the two stocks.